ReviewCancers2022

Chimeric Antigen Receptor T-Cell Therapy in Metastatic Castrate-Resistant Prostate Cancer.

Mahasha P J Perera et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.